Skip to main content
. Author manuscript; available in PMC: 2017 Jan 20.
Published in final edited form as: Anticancer Res. 2014 Jul;34(7):3357–3363.

Table I.

Effect of Lipitor and Celebrex on apoptosis of VCaP cells. VCaP cells were seeded at a density of 0.2×105 cells/ml and incubated for 24 h. The cells were then treated with Lipitor (10 μM) or Celebrex (10 μM) alone or in combination for 96 h. Apoptosis was determined by morphological assessment and caspase-3 assay. Each value is the mean ± S.E from three experiments. Differences for the number of apoptotic cells and caspase-3 activation between a combination group and a single agent-treated group were analyzed by ANOVA with the Tukey-Kramer multiple comparison test.

Treatment Apoptotic cells (%) Caspase-3 activity
Control 2.3 ± 0.3 1.0
Lipitor 15.2 ± 2.6 6.7 ± 1.2
Celecoxib 12.7 ± 3.6 6.4 ± 2.1
Combination 37.8 ± 6.1* 18.1 ± 3.4*
*

p<0.001 as compared to Lipitor or Celebrex alone.